News and publications
Promethera Biosciences raises €25.33 million ($31.4 million) in Series C financial round
Mont-Saint-Guibert (Belgium), November 25, 2014 – Promethera Biosciences today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
The financing round is supported by existing Promethera Biosciences investors and two new investors: SFPI-FPIM, the Belgian Federal Holding and Investment Company, and SMS Investments, a Luxemburg based subsidiary office of the German SMS group.
Download this file (EN)
Download this file (FR)
Download this file (NL)
PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01